Ignite Creation Date:
2025-12-24 @ 12:09 PM
Ignite Modification Date:
2025-12-31 @ 1:36 AM
Study NCT ID:
NCT03318861
Status:
TERMINATED
Last Update Posted:
2023-10-19
First Post:
2017-10-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma
Sponsor:
Kite, A Gilead Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-20
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-16
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-13
First Submit QC Date:
None
Study First Post Date:
2017-10-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-05-06
Results First Submit QC Date:
None
Results First Post Date:
2020-05-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-17
Last Update Post Date:
2023-10-19
Last Update Post Date Type:
ACTUAL